Sarkar, Hajrah;
Moosajee, Mariya;
(2022)
Choroideremia: molecular mechanisms and therapies.
Trends in Molecular Medicine
, 28
(5)
pp. 378-387.
10.1016/j.molmed.2022.02.011.
Preview |
Text
Moosajee_Choroideremia Molecular mechanisms and therapies.pdf Download (285kB) | Preview |
Abstract
Choroideremia (CHM) is a monogenic X-linked chorioretinal dystrophy affecting the photoreceptors, retinal pigment epithelium (RPE), and choroid; it is caused by mutations involving the CHM gene. CHM is characterized by night blindness in early childhood, progressing to peripheral visual field loss and eventually to complete blindness from middle age. CHM encodes the ubiquitously expressed Rab escort protein 1 (REP1), which is responsible for prenylation of Rab proteins and is essential for intracellular trafficking of vesicles. In this review we explore the role of REP1 in the retina and its newly discovered systemic manifestations, and discuss the therapeutic strategies for tackling this disease, including the outcomes from recent clinical trials.
Type: | Article |
---|---|
Title: | Choroideremia: molecular mechanisms and therapies |
Location: | England |
Open access status: | An open access version is available from UCL Discovery |
DOI: | 10.1016/j.molmed.2022.02.011 |
Publisher version: | https://doi.org/10.1016/j.molmed.2022.02.011 |
Language: | English |
Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
Keywords: | Choroideremia, CHM, REP1, gene therapy, metabolomics, nonsense suppression therapy |
UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Brain Sciences > Institute of Ophthalmology |
URI: | https://discovery-pp.ucl.ac.uk/id/eprint/10203087 |
Archive Staff Only
![]() |
View Item |